Uric acid and nocturnal nondipping in hypertensive patients with normal renal function

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 406-411

  Afsar, Baris ^a,b   Elsurer, Rengin ^a   Ozdemir, Fatma Nurhan ^a   Sezer, Siren ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Ambulatory blood pressure; Dipper; Fasting blood glucose; Nocturnal blood pressure; Nondipper; Uric acid

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MONITORING; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NIGHT; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; URINALYSIS; BLOOD; BLOOD PRESSURE; CIRCADIAN RHYTHM; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; URIC ACID;

EID: 52049104260     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7-13.
2. Alderman MH. Serum uric acid as a cardiovascular risk factor for heart disease. Curr Hypertens Rep. 2001;3:184-189.
3. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis. 1999;33:225-234.
4. Bellomo G, Berardi P, Saronio P, et al. Microalbuminuria and uric acid in healthy subjects. J Nephrol. 2006;19:458-464.
5. Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens. 2001;10:611-616.
6. Zhou X, Matavelli L, Frohlich ED. Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006;8:120-124.
7. Torun D, Sezer S, Arat Z, Pelit A, Yigit F, Ozdemir FN. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Int Heart J. 2005;46:1073-1082.
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
9. O'Brien E, Pickering T, Asmar R, et al; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit. 2002;7:3-17.
10. Jones SC, Bilous M, Winship S, Finn P, Goodwin J. Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Press Monit. 2004;9:219-223.
11. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-1190.
12. Feig DI, Nakagawa T, Karumanchi SA, et al. Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66:281-287.
13. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247-252.
14. Perlstein TS, Gumieniak O, Hopkins PN, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66:1465-1470.
15. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966;275:457-464.
16. Ferris TF, Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med. 1968;44:359-365.
17. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects: evaluation by power spectral analysis of heart rate variability. Hypertension. 1995;26:808-814.
18. Chen JW, Jen SL, Lee WL, et al. Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care. 1998;21:1743-1748.
19. Ragot S, Herpin D, Siche JP, Ingrand P, Mallion JM. Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients: what about sex differences? J Hypertens. 1999;17:1805-1811.
20. Ragot S, Herpin D, Siche JP, Poncelet P, Mallion JM. Relationship between short-term and long-term blood pressure variabilities in essential hypertensives. J Hum Hypertens. 2001;15:41-48.
21. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J Hypertens. 1998;16:1335-1343.
22. Lembo G, Capaldo B, Rendina V, et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol. 1994;266:E242-7.